Skip to main content
. 2015 Aug 15;17(1):212. doi: 10.1186/s13075-015-0728-9

Fig. 2.

Fig. 2

Relative risk of overall malignancy in patients with rheumatoid arthritis (RA) compared with the general population. CI, confidence interval; DMARD, disease-modifying antirheumatic drug; n, number of malignancies; N, population size; RR, relative risk; SIR, standardized incidence ratio; TNF, tumor necrosis factor. *SIRs by sex are not included in the total pooled SIR. Excluding non-melanoma skin cancer. All solid tumors. §Excluding lymphatic and hematopoietic